| Duramycin | Streptomyces cinnamomeus NRRL B-1699 | Lantibiotic | |
| Salivaricin A | Streptococcus salivarius K12 | Lantibiotic | | Gastrointestinal tract infections | Oral cavity | - in-vitro
- in-vivo (animal model / human model)
| Burton et al. 2010 | | Gastrointestinal tract infections | Oral cavity | - in-vitro
- in-vivo (animal model / human model)
| Burton et al. 2006 | | Gastrointestinal tract infections | Oral cavity | - in-vitro
- in-vivo (animal model / human model)
| Burton et al. 2011 |
|
| Salivaricin B | Streptococcus salivarius K12 | Lantibiotic | | Gastrointestinal tract infections | Oral cavity | - in-vitro
- in-vivo (animal model / human model)
| Burton et al. 2010 | | Gastrointestinal tract infections | Oral cavity | - in-vitro
- in-vivo (animal model / human model)
| Burton et al. 2006 | | Gastrointestinal tract infections | Oral cavity | - in-vitro
- in-vivo (animal model / human model)
| Burton et al. 2011 |
|
| Salivaricin D | Streptococcus salivarius 5M6c | Lantibiotic | |
| Nisin U | Lactococcus lactis spp. | Lantibiotic | |